/CLVR
CLVR Stock - Clever Leaves Holdings Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00-66.67%
$0.00 (-66.67%) • Dec 19
40
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.20
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CLVR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta4.48
52W High$0.50
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $17.42M | $16.41M | $15.37M | $12.12M | $7.83M |
| Gross Profit | $6.56M | $4.33M | $6.81M | $7.41M | $3.10M |
| Gross Margin | 37.6% | 26.4% | 44.3% | 61.2% | 39.6% |
| Operating Income | $-15,594,000 | $-21,470,000 | $-38,699,000 | $-26,846,000 | $-36,540,000 |
| Net Income | $-17,899,000 | $-66,101,000 | $-45,631,000 | $-36,114,000 | $-45,980,000 |
| Net Margin | -102.8% | -402.8% | -296.8% | -298.0% | -586.9% |
| EPS | $-11.42 | $-51.65 | $-53.29 | $-43.54 | $-184.77 |
Company Overview
Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CLVRBeat Rate
8%
Last 12 quarters
Avg Surprise
-1926.3%
EPS vs Estimate
Beats / Misses
1/11
Last 12 quarters
Latest EPS
$-2.96
Q2 2024
EPS Surprise History
Q2 22
-3450.0%
$-15.62vs$-0.44
Q3 22
-2513.0%
$-6.01vs$-0.23
Q4 22
-3258.8%
$-5.71vs$-0.17
Q1 23
-2500.0%
$-3.90vs$-0.15
Q2 23
-1700.0%
$-2.70vs$-0.15
Q3 23
-2233.3%
$-2.10vs$-0.09
Q4 23
-119.0%
$-4.60vs$-2.10
Q2 24
-41.0%
$-2.96vs$-2.10
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Jun 4, 2025 | — | — | — | — |
Q2 2025 | May 30, 2025 | — | — | — | — |
Q1 2025 | Feb 28, 2025 | — | — | — | — |
Q4 2024 | Nov 18, 2024 | — | — | — | — |
Q3 2024 | Aug 30, 2024 | — | — | — | — |
Q2 2024 | Apr 1, 2024 | $-2.10 | $-2.96 | -41.0% | ✗ MISS |
Q1 2024 | Mar 28, 2024 | — | — | — | — |
Q4 2023 | Nov 9, 2023 | $-2.10 | $-4.60 | -119.0% | ✗ MISS |
Q3 2023 | Aug 14, 2023 | $-0.09 | $-2.10 | -2233.3% | ✗ MISS |
Q2 2023 | May 11, 2023 | $-0.15 | $-2.70 | -1700.0% | ✗ MISS |
Q1 2023 | Mar 30, 2023 | $-0.15 | $-3.90 | -2500.0% | ✗ MISS |
Q4 2022 | Nov 9, 2022 | $-0.17 | $-5.71 | -3258.8% | ✗ MISS |
Q3 2022 | Aug 11, 2022 | $-0.23 | $-6.01 | -2513.0% | ✗ MISS |
Q2 2022 | May 12, 2022 | $-0.44 | $-15.62 | -3450.0% | ✗ MISS |
Q1 2022 | Mar 24, 2022 | $-0.53 | $-5.11 | -864.2% | ✗ MISS |
Q4 2021 | Nov 10, 2021 | $-0.40 | $-13.21 | -3202.5% | ✗ MISS |
Q3 2021 | Aug 12, 2021 | $-0.36 | $-0.35 | +2.8% | ✓ BEAT |
Q3 2021 | Aug 12, 2021 | $-0.36 | $-12.01 | -3236.1% | ✗ MISS |
Q2 2021 | May 17, 2021 | — | $-10.81 | — | — |
Q1 2021 | Mar 30, 2021 | — | $-19.49 | — | — |
Latest News
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
📈 PositiveBenzinga•Dec 18, 2025, 12:21 PM•Also: , ,
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
📈 PositiveBenzinga•Dec 17, 2025, 01:38 PM•Also: , ,
Frequently Asked Questions about CLVR
What is CLVR's current stock price?
Clever Leaves Holdings Inc. (CLVR) is currently trading at $0.00 per share. The stock has moved -66.67% today.
What is the analyst price target for CLVR?
No analyst price targets are currently available for this stock.
What sector is Clever Leaves Holdings Inc. in?
Clever Leaves Holdings Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is CLVR's market cap?
Clever Leaves Holdings Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does CLVR pay dividends?
No, Clever Leaves Holdings Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBIOCQ
Biocept, Inc.
$0.00
Mkt Cap: $0.0B
BRSF
Brain Scientific Inc.
$0.00
Mkt Cap: $0.0B
BSPM
Biostar Pharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
CRFTF
BC Craft Supply Co. Ltd.
$0.00
Mkt Cap: $0.0B
ENCW
Enchanted World Inc.
$0.00
Mkt Cap: $0.0B
HLTHQ
Cue Health Inc.
$0.00
Mkt Cap: $0.0B
HTGMQ
HTG Molecular Diagnostics, Inc.
$0.00
Mkt Cap: $0.0B
NEXI
NexImmune, Inc.
$0.00
Mkt Cap: $0.0B
PPII
Coenzyme-A Inc.
$0.00
Mkt Cap: $0.0B
VRCI
Verde Science, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to CLVR for comparison